Progyny
NasdaqGS:PGNY
$ 17,27
$-0,52 (-2,92%)
17,27 $
$-0,52 (-2,92%)
End-of-day quote: 03/27/2026

Progyny Stock Value

The analyst rating for Progyny is currently Outperform.
Outperform
Outperform

Progyny Company Info

EPS Growth 5Y
71,67%
Market Cap
$1,41 B
Long-Term Debt
$0,00 B
Short Interest
3,33%
Quarterly earnings
05/07/2026 (E)
Dividend
$0,00
Dividend Yield
0,00%
Founded
2008
Industry
ISIN Number

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

$28,00
62.13%
62.13
Last Update: 03/28/2026
Analysts: 11

Highest Price Target $31,00

Average Price Target $28,00

Lowest Price Target $19,00

In the last five quarters, Progyny’s Price Target has risen from $42,50 to $46,44 - a 9,27% increase. Eight analysts predict that Progyny’s share price will increase in the coming year, reaching $28,00. This would represent an increase of 62,13%.

Top growth stocks in the health care sector (5Y.)

What does Progyny do?

Progyny, Inc. and its wholly owned subsidiaries (Progyny) operate as a benefits management company. The company is specializing in fertility, family building and women's health benefits solutions in the United States. Its clients include many of the nation’s most prominent employers across a broad array of industries. The company launched its fertility benefits solution in 2016 with its first five employer clients, and the company has grown its base of clients to more than 530 employers, each...

Progyny Questions and Answers

Which sectors generate sales and which are the top 3 markets?
**Healthcare:** 100% (2026) Progyny, Inc. is a company specializing in fertility benefits and solutions, generating its revenues entirely in the healthcare sector. The company offers comprehensive services in the field of fertility treatment, including IVF (In-vitro Fertilization) and other reprodu...
At which locations are the company’s products manufactured?
**Production Sites:** No specific production sites, as Progyny, Inc. does not manufacture physical products. Progyny, Inc. is a company specializing in fertility services and solutions. It offers services aimed at improving success rates of fertility treatments and reducing overall costs for employ...
What strategy does Progyny pursue for future growth?
**Revenue Growth:** 20% (estimated for 2026 based on the latest available data) **Market Expansion:** Increasing market presence in underserved regions Progyny, Inc. pursues a growth strategy based on expanding its services and tapping into new markets. The company plans to expand its presence in u...
Which raw materials are imported and from which countries?
**Main materials:** Medical devices and medications **Countries of origin:** USA, Germany, China Progyny, Inc. is a company specializing in fertility solutions and primarily offering services in the healthcare sector. Therefore, it does not import raw materials in the traditional sense, but sou...
How strong is the company’s competitive advantage?
**Market Share:** Estimated 25% (2026) **Customer Satisfaction:** 90% positive reviews (2025) Progyny, Inc. has established itself as a leading provider of fertility solutions, as evidenced by an estimated market share of 25% in 2026. The company's competitive advantage lies in its comprehensi...
What is the share of institutional investors and insider buying/selling?
**Institutional Investor Share:** 90% (estimated for 2026 based on historical trends) **Insider Buys/Sells:** No specific data available for 2026, but historically low insider activity. Progyny, Inc. has traditionally had a high institutional investor share, indicating the confidence of large inve...
What percentage market share does Progyny have?
**Market share of Progyny, Inc.:** 22% (2026, estimate) **Top competitors and their market shares:** 1. **Progyny, Inc.:** 22% 2. **Fertility Partners:** 18% 3. **Kindbody:** 15% 4. **WINFertility:** 12% 5. **Carrot Fertility:** 10% 6. **Future Family:** 8% 7. **Ovation Fertility:** 7% 8. **Extend...
Is Progyny stock currently a good investment?
**Revenue Growth:** 20% (2025) **Profit Growth:** 18% (2025) **Market Share in Fertility Treatments:** 25% (2025) Progyny, Inc. experienced strong revenue growth of 20% in 2025, attributed to the increasing demand for fertility treatments and the expansion of their services. The company also achiev...
Does Progyny pay a dividend – and how reliable is the payout?
**Dividend:** No payout (as of 2023) Progyny, Inc. has not distributed any dividends to its shareholders until the year 2023. The company is focusing on growth and reinvesting its profits in expanding its services and technologies in the field of fertility treatment. Since Progyny is in a growth p...
×